238 related articles for article (PubMed ID: 2470847)
1. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
[TBL] [Abstract][Full Text] [Related]
2. Purified human basophils do not generate LTB4.
Warner JA; Freeland HS; MacGlashan DW; Lichtenstein LM; Peters SP
Biochem Pharmacol; 1987 Oct; 36(19):3195-9. PubMed ID: 2444228
[TBL] [Abstract][Full Text] [Related]
3. Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells.
Warner JA; Lichtenstein LM; MacGlashan DW
J Pharmacol Exp Ther; 1988 Oct; 247(1):218-22. PubMed ID: 3139865
[TBL] [Abstract][Full Text] [Related]
4. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of cytosolic phospholipase A2 by IL-3 is associated with increased free arachidonic acid generation and leukotriene C4 release in human basophils.
Miura K; Hubbard WC; MacGlashan DW
J Allergy Clin Immunol; 1998 Sep; 102(3):512-20. PubMed ID: 9768595
[TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils.
Miura K; Schroeder JT; Hubbard WC; MacGlashan DW
J Immunol; 1999 Apr; 162(7):4198-206. PubMed ID: 10201947
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
Warner JA; MacGlashan DW
J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
10. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine.
de Paulis A; Ciccarelli A; de Crescenzo G; Cirillo R; Patella V; Marone G
J Allergy Clin Immunol; 1996 Jul; 98(1):152-64. PubMed ID: 8765829
[TBL] [Abstract][Full Text] [Related]
12. Benzene metabolites inhibit the release of proinflammatory mediators and cytokines from human basophils.
Borrelli I; Loffredo S; Staiano RI; Frattini A; Marone G; Triggiani M
Int J Immunopathol Pharmacol; 2010; 23(3):737-44. PubMed ID: 20943043
[TBL] [Abstract][Full Text] [Related]
13. The effect of pertussis toxin on mediator release from human basophils.
Warner JA; Yancey KB; MacGlashan DW
J Immunol; 1987 Jul; 139(1):161-5. PubMed ID: 2438348
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and metabolism of leukotrienes by human endothelial cells: influence on prostacyclin release.
Ibe BO; Campbell WB
Biochim Biophys Acta; 1988 Jun; 960(3):309-21. PubMed ID: 2838089
[TBL] [Abstract][Full Text] [Related]
15. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils.
Lie WJ; Homburg CH; Kuijpers TW; Knol EF; Mul FP; Roos D; Tool AT
Clin Exp Allergy; 2003 Aug; 33(8):1125-34. PubMed ID: 12911788
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 3-dependent mediator release in basophils triggered by C5a.
Kurimoto Y; de Weck AL; Dahinden CA
J Exp Med; 1989 Aug; 170(2):467-79. PubMed ID: 2474054
[TBL] [Abstract][Full Text] [Related]
17. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release.
Hundley TR; Marshall LA; Hubbard WC; MacGlashan DW
J Pharmacol Exp Ther; 1998 Mar; 284(3):847-57. PubMed ID: 9495842
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human basophil leukotriene release by antiinflammatory steroids.
Schleimer RP; Davidson DA; Peters SP; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):241-3. PubMed ID: 3874167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
